Inoue Masaki, Shimizu Yuichi, Ishikawa Marin, Abiko Satoshi, Shimoda Yoshihiko, Tanaka Ikko, Kinowaki Sayoko, Ono Masayoshi, Yamamoto Keiko, Ono Shoko, Sakamoto Naoya
Department of Gastroenterology and Hepatology, Graduate School of Medicine and Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido 060-0808, Japan.
Division of Endoscopy, Hokkaido University Hospital, Sapporo, Hokkaido 060-8648, Japan.
World J Gastroenterol. 2020 Oct 21;26(39):6047-6056. doi: 10.3748/wjg.v26.i39.6047.
It is well known that an alcohol consumption habit together with inactive heterozygous aldehyde dehydrogenase-2 (ALDH2) is an important risk factor for the development of esophageal squamous cell carcinoma (ESCC). It remains controversial whether human papillomavirus (HPV) infection contributes to the occurrence/development of ESCC. There has been no study in which the relationship between ESCC and HPV in addition to alcohol dehydrogenase-1B (ADH1B) and ALDH2 genotypes was evaluated.
To evaluate relationships between HPV infection and development of esophageal cancer, particularly early esophageal cancer, based on ADH1B/ALDH2 polymorphisms.
We conducted an exploratory retrospective study using new specimens, and we enrolled 145 patients who underwent endoscopic resection for superficial ESCC and had been observed for more than two years by both physical examination and endoscopic examination in Hokkaido University Hospital. Saliva was collected to analyze genetic polymorphisms of ADH1B/ALDH2. We performed in situ hybridization for resected specimens to detect HPV by using an HPV type 16/18 probe.
HPV was detected in 15 (10.3%) of the 145 patients with ESCC. HPV-positive rates in inactive ALDH2*1/2 and ALDH21/*1 + *2/2 were 10.8% and 9.8%, respectively ( = 1.00). HPV-positive rates in slow-metabolizing ADH1B1/1 and ADH1B1/*2 + *2/*2 were 12.0% and 10.0%, respectively ( = 0.72). HPV-positive rates in the heavy or moderate alcohol consumption group and the light or rare consumption group were 11.1% and 8.7%, respectively ( = 0.68). HPV-positive rates in the heavy smoking group and the light or no smoking group were 11.8% and 8.3%, respectively ( = 0.59). The 3-year incidence rates of secondary ESCC or head and neck cancer after initial treatment in the HPV-positive and HPV-negative groups were 14.4% and 21.4% ( = 0.22), respectively.
In the present situation, HPV status is considered to be less important than other risk factors, such as alcohol consumption, smoking habit, ADH1B/ALDH2 polymorphisms, and HPV status would therefore have no effect on ESCC risk management.
众所周知,饮酒习惯与无活性杂合醛脱氢酶2(ALDH2)是食管鳞状细胞癌(ESCC)发生的重要危险因素。人乳头瘤病毒(HPV)感染是否促成ESCC的发生/发展仍存在争议。尚未有研究评估ESCC与HPV之间的关系以及乙醇脱氢酶1B(ADH1B)和ALDH2基因型。
基于ADH1B/ALDH2多态性评估HPV感染与食管癌尤其是早期食管癌发生之间的关系。
我们使用新标本进行了一项探索性回顾性研究,纳入了145例行浅表性ESCC内镜切除术且在北海道大学医院通过体格检查和内镜检查观察超过两年的患者。收集唾液以分析ADH1B/ALDH2的基因多态性。我们对切除标本进行原位杂交,使用HPV 16/18型探针检测HPV。
145例ESCC患者中有15例(10.3%)检测到HPV。无活性ALDH2*1/2和ALDH21/*1 + *2/2中的HPV阳性率分别为10.8%和9.8%(P = 1.00)。慢代谢型ADH1B1/1和ADH1B1/*2 + *2/*2中的HPV阳性率分别为12.0%和10.0%(P = 0.72)。重度或中度饮酒组与轻度或偶尔饮酒组的HPV阳性率分别为11.1%和8.7%(P = 0.68)。重度吸烟组与轻度或不吸烟组的HPV阳性率分别为11.8%和8.3%(P = 0.59)。HPV阳性组和HPV阴性组初始治疗后3年发生继发性ESCC或头颈癌的发生率分别为14.4%和21.4%(P = 0.22)。
在当前情况下,HPV状态被认为比饮酒、吸烟习惯、ADH1B/ALDH2多态性等其他危险因素的重要性低,因此HPV状态对ESCC风险管理无影响。